Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

L. P. Stabile, G. He, V. W. Lui, S. Thomas, C. Henry, C. T. Gubish, S. Joyce, K. M. Quesnelle, J. M. Siegfried, Grandis

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)3715
Number of pages1
JournalClinical Cancer Research
Issue number13
StatePublished - Jul 1 2013

Cite this